Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ALXN - Is Alexion Pharmaceuticals a Buy?


ALXN - Is Alexion Pharmaceuticals a Buy?

There are plenty of promising biotech stocks for investors to sift through right now. One of these companies is Alexion Pharmaceuticals (NASDAQ: ALXN), a developer of treatments for rare diseases that has seen tremendous success with its flagship drug, Soliris.

With management expecting further sales growth, there's a lot of potential upside for this company in the future. At the same time, its shares are trading quite cheaply in comparison to other biotech companies'.

Does that make this stock an automatic buy in 2020? Let's find out.

Continue reading

Stock Information

Company Name: Alexion Pharmaceuticals Inc.
Stock Symbol: ALXN
Market: NASDAQ
Website: alexion.com

Menu

ALXN ALXN Quote ALXN Short ALXN News ALXN Articles ALXN Message Board
Get ALXN Alerts

News, Short Squeeze, Breakout and More Instantly...